# Observational malaria studies recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials that are observational for malaria that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational malaria studies: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/malaria

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07935109 | Management of Severe Plasmodium Falciparum Malaria With Oral Artemisinin Derivatives | Centre Hospitalier de Saint-Denis | Observational | Recruiting | Malaria, Falciparum, Plasmodium Falciparum, Artemisinins, Antimalarials, Artesunate, Treatment Outcome | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935109) |
| October 27, 2026 | NCT07896746 | Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and Rwanda | Novartis Pharmaceuticals | Observational | Not yet recruiting | Malaria | 184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896746) |
| September 25, 2026 | NCT07840898 | Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Ethiopian Public Health Institute | Observational | Not yet recruiting | Plasmodium Vivax Malaria Without Complication, Plasmodium Falciparum Malaria (Uncomplicated) | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840898) |
| August 18, 2026 | NCT07770048 | Community-Based Cohort Study of Hidden Malaria Infections, Diagnostic Gaps, & Mosquito Vector Dynamics in Odisha, India | London School of Hygiene and Tropical Medicine | Observational | Recruiting | Malaria, Asymptomatic Parasitaemia | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770048) |
| August 6, 2026 | NCT07749911 | Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT) | Clinton Health Access Initiative Inc. | Observational | Recruiting | Malaria, PLASMODIUM FALCIPARUM MALARIA | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749911) |
| March 9, 2026 | NCT07456969 | Non-invasive Malaria Diagnostic Data Collection in Ethiopia | Foundation for Innovative New Diagnostics, Switzerland | Observational | Recruiting | Malaria Fever | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07456969) |
| February 18, 2026 | NCT07416461 | Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease | International Vaccine Institute | Observational | Recruiting | Invasive Non-Typhoidal Salmonella Disease, Malaria, Malaria Vaccine | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416461) |
| January 22, 2026 | NCT07358910 | Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | Institut Pasteur du Cambodge | Observational | Recruiting | Dengue, Chikungunya, Zika Virus Infection, Japanese Encephalitis, West Nile Virus, Tick-borne Encephalitis (TBE)... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07358910) |
| January 15, 2026 | NCT07345286 | Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC | Institute of Tropical Medicine, Belgium | Observational | Recruiting | Febrile Illness Acute, Biomarkers, Surveillance | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07345286) |
| December 8, 2025 | NCT07269314 | Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Malaria, Pneumocystis, Leishmania | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269314) |
| June 8, 2025 | NCT07009847 | An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine | Serum Institute of India Pvt. Ltd. | Observational | Recruiting | Malaria,Falciparum, Morality | 2,308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07009847) |
| February 11, 2025 | NCT06821282 | Surveillance of AMR in DRC | University of Oxford | Observational | Recruiting | Bacteremia | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06821282) |
| August 15, 2024 | NCT06555809 | Evaluation of Artesunate in Infants Being Treated for Severe Malaria | Amivas Inc. | Observational | Recruiting | Malaria | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06555809) |
| June 21, 2024 | NCT06468319 | Pregnancy Registry in Mali | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Malaria, Pregnancy Related | 9,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06468319) |
| May 17, 2024 | NCT06418256 | Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Splenectomy | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06418256) |
| March 18, 2022 | NCT05285735 | Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants | Amivas Inc. | Observational | Recruiting | Pregnancy, Malaria | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05285735) |
| September 13, 2021 | NCT05041556 | Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine | Kintampo Health Research Centre, Ghana | Observational | Recruiting | Malaria | 9,280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05041556) |
| May 6, 2019 | NCT03937817 | Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Alpha and Beta Thalassemia, Sickle Cell Disease, Malaria, Human Physiology | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03937817) |
| December 24, 2015 | NCT02639299 | Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Malaria | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02639299) |
| June 15, 2015 | NCT02471378 | Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Malaria | 7,476 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02471378) |
| July 23, 2010 | NCT01168271 | Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in... | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Malaria | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01168271) |
| November 4, 1999 | NCT00001645 | Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Malaria, Intestinal Worms, GI Protozoa, Echiniococcus, Strongyloides | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00001645) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Amivas Inc. | 2 |
| [Serum Institute of India Pvt. Ltd.](https://specstream.ai/data/clinical-trials/company/serum-institute-of-india-pvt-ltd) | 1 |
| Institute of Tropical Medicine, Belgium | 1 |
| Foundation for Innovative New Diagnostics, Switzerland | 1 |
| Kintampo Health Research Centre, Ghana | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
| Institut Pasteur du Cambodge | 1 |
| International Vaccine Institute | 1 |
| Clinton Health Access Initiative Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| London School of Hygiene and Tropical Medicine | 1 |
| Ethiopian Public Health Institute | 1 |
| University of Oxford | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 4 |
| Mali | 3 |
| Democratic Republic of the Congo | 3 |
| France | 3 |
| Burkina Faso | 2 |
| Uganda | 2 |
| Ethiopia | 2 |
| Côte d’Ivoire | 1 |
| Nigeria | 1 |
| Ghana | 1 |
| Kenya | 1 |
| Malawi | 1 |
| Cambodia | 1 |
| India | 1 |
| Italy | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Public utilities in the United States](https://specstream.ai/data/businesses/public-utilities/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
- [Auto lenders in the United States](https://specstream.ai/data/businesses/auto-lenders/united-states)
- [Child care centers in the United States](https://specstream.ai/data/businesses/child-care-centers/united-states)
- [Equipment rental companies in the United States](https://specstream.ai/data/businesses/equipment-rental-companies/united-states)
- [Immunodermatology practices in the United States](https://specstream.ai/data/businesses/immunodermatology-practices/united-states)
